lorazepam has been researched along with vigabatrin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodie, JD; Dewey, SL; Ferrieri, RA; King, PT; Logan, J; MacGregor, RR; Martin, TP; Smith, GS; Wolf, AP; Yu, DW | 1 |
| Petersen, EN; Rasmussen, KJ; Schneider, HH | 1 |
| Alexoff, DL; Brodie, JD; Chaurasia, CS; Chen, CE; Clarkson, FA; Dewey, SL; Fowler, JS; Porter, SP; Russo, NB; Straughter-Moore, RM; Tedeschi, D; Volkow, ND | 1 |
| Hildebrandt, J; Paulus, W; Tergau, F; Wischer, S; Ziemann, U | 1 |
| de Angelis, L; Lang, AP | 1 |
| Amad, A; Corfiotti, C; Ferrafiat, V; Jardri, R; Leroy, A; Medjkane, F; Nguyen The Tich, S | 1 |
1 review(s) available for lorazepam and vigabatrin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and vigabatrin
| Article | Year |
|---|---|
Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Central Nervous System Depressants; Cyclohexanecarboxylic Acids; Electric Stimulation; Ethanol; Evoked Potentials, Motor; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lorazepam; Male; Motor Cortex; Neural Inhibition; Phenobarbital; Transcranial Magnetic Stimulation; Triazines; Vigabatrin | 1998 |
6 other study(ies) available for lorazepam and vigabatrin
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.
Topics: Aminocaproates; Animals; Brain; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine; Female; gamma-Aminobutyric Acid; Lorazepam; Neurotransmitter Agents; Papio; Raclopride; Salicylamides; Tomography, Emission-Computed; Vigabatrin | 1992 |
Sodium valproate exerts anti-conflict activity in rats without any concomitant rise in forebrain GABA level.
Topics: Aminocaproates; Aminooxyacetic Acid; Animals; Behavior, Animal; Brain; Conflict, Psychological; Dose-Response Relationship, Drug; Electroshock; gamma-Aminobutyric Acid; Lorazepam; Male; Rats; Valproic Acid; Vigabatrin | 1981 |
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity.
Topics: 4-Aminobutyrate Transaminase; Animals; Cocaine; Corpus Striatum; Dopamine; Enzyme Inhibitors; Ethanol; GABA Modulators; gamma-Aminobutyric Acid; Lorazepam; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors; Vigabatrin | 1997 |
Experimental anxiety and antiepileptics: the effects of valproate and vigabatrin in the mirrored chamber test.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Female; Injections, Intraperitoneal; Lorazepam; Maze Learning; Mice; Piperazines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Receptor Agonists; Valproic Acid; Vigabatrin | 2003 |
Catatonia Associated With a
Topics: Anticonvulsants; Catatonia; Child, Preschool; Humans; Lorazepam; Mutation; NAV1.2 Voltage-Gated Sodium Channel; Seizures; Vigabatrin | 2018 |